Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Binding of SCF by the

Binding of SCF by the c-Kit receptor leads to homodimerization of the receptor and the activation of signalling pathways such as PI-3

General Protocols:

: IHC0181R

which plays an important role in cell-cell interactions

which may have strong effects on the differentiation and growth of epithelial cells

Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Binding of SCF by theApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name FceR2 CD23 Target Uniprot P06734 Overview Catalog# BIO0588SM Product Name Anti human FceR2 CD23 (Lumiliximab Biosimilar) Specifications Conjugation None Clone# Lumiliximab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O